Video to Promote HPV Vaccination

Health Behavior Clinical Trial

Official title:

Educating Pre/Teens and Their Parents on the Importance of HPV Vaccination

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02196454
• Other study ID #: IRB 14-011091
• Status: Completed
• Phase: N/A
• Start date: July 2014
• Est. completion date: May 31, 2018

Study information

• Verified date: May 2018
• Source: Children's Hospital of Philadelphia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.

Description:

Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.

Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates

Recruitment information / eligibility

• Status: Completed
• Enrollment: 110
• Est. completion date: May 31, 2018
• Est. primary completion date: December 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 11 Years and older

Eligibility

Inclusion Criteria:

• Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine

Exclusion Criteria:

• Parent-child dyads in which the child has received the HPV vaccine

• Parent-child dyads in which the child is older than 18 at the time of enrollment

• Non-English speakers

Related Conditions & MeSH terms

• Acceptance Processes
• Health Behavior
• Human Papillomavirus
• Social Acceptance
• Vaccine Acceptance

Intervention

Other:
• Educational Video with Male or Female Narrator
Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.

Locations

Country	Name	City	State
United States	Primary Care, Flourtown, Children's Hospital of Philadelphia	Flourtown	Pennsylvania
United States	Nicholas and Athena Karabots Pediatric Care Center	Philadelphia	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
Children's Hospital of Philadelphia	Noble Medical, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	HPV Vaccine Awareness	Reported reason for HPV vaccine receipt or deferral	0 days
Primary	HPV Vaccination Series Initiation	Number of HPV vaccine doses received among study participants	90 days
Primary	HPV Vaccine Series Initiation	HPV Vaccine Receipt among study participants	0 days
Secondary	HPV Vaccine Series Initiation (depending on male versus female narrator)	Difference in rate of HPV vaccine receipt between study participants who viewed a video narrated by a male versus a female	0 days
Secondary	HPV Vaccine Series Initiation (depending on male versus female narrator)	Difference in number of HPV vaccine doses between study participants who viewed a video narrated by a male versus a female	90 days